Meyahealth
Home
ENES
HomeGeneticsGeneSATB2 gene
Back to Gene

SATB2 gene

Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

SATB2 gene

The SATB2 gene provides instructions for a protein that regulates gene expression during development, particularly in the brain, bones, and craniofacial structures.

Normal Function

The SATB2 gene provides instructions for making a protein that attaches to specific DNA regions called matrix attachment regions (MARs). By organizing the structure of chromatin, the SATB2 protein coordinates the activity of multiple genes involved in development.

The protein is particularly important for promoting the maturation of bone-building cells (osteoblasts), directing the development of structures in the head and face, and supporting the maturation and function of neurons in the brain.

Health Conditions Related to Genetic Changes

SATB2-associated syndrome

Mutations in the SATB2 gene cause SATB2-associated syndrome, a condition characterized by intellectual disability and severe speech problems. Individuals may also experience dental abnormalities, an opening in the roof of the mouth, and other craniofacial anomalies.

These mutations—which can include large deletions, rearrangements, or single nucleotide changes—generally result in a reduction of functional SATB2 protein. This deficiency impairs the normal development of the brain and facial structures. In cases involving large deletions that remove neighboring genes, individuals may also experience uncommon features such as heart, skin, hair, or genitourinary tract problems.

Other Names for This Gene

  • DNA-binding protein SATB2
  • FLJ21474
  • GLSS
  • KIAA1034
  • SATB family member 2
  • special AT-rich sequence-binding protein 2

Frequently Asked Questions

Children with SATB2‑associated syndrome often show delayed speech, mild to moderate intellectual disability, and characteristic craniofacial features such as a cleft palate or dental abnormalities. These signs can appear in the first year of life, especially if a cleft palate is present, and speech delays are usually evident by 18–24 months. Early developmental screening and a multidisciplinary evaluation (speech therapy, orthodontics, and neurology) can help identify and address these issues sooner.
Diagnosis is confirmed by genetic testing that identifies pathogenic variants in the SATB2 gene. The most common methods are chromosomal microarray (to detect deletions or duplications) and targeted next‑generation sequencing panels or whole‑exome sequencing. Parents should expect a pre‑test counseling session, a blood draw, and a 4–6 week turnaround for results. A detailed interpretation will guide management and family planning.
Early intervention is key. Speech and language therapy should start as soon as speech delays are noted, ideally before 12 months of age. Therapists often use a combination of augmentative communication, phonological awareness training, and motor speech exercises. Consistent home practice and regular follow‑ups (every 3–6 months) help track progress and adjust goals.
While the core features involve the brain and craniofacial structures, large deletions that include neighboring genes can lead to cardiac defects, skin abnormalities, or renal anomalies. A baseline cardiac evaluation (echocardiogram) and kidney function tests (serum creatinine, urinalysis) are recommended at diagnosis, with repeat monitoring every 1–2 years or sooner if symptoms arise. Early detection allows timely intervention and reduces long‑term complications.===
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.